AU2009276343A1 - Methionine analogs and methods of using same - Google Patents

Methionine analogs and methods of using same Download PDF

Info

Publication number
AU2009276343A1
AU2009276343A1 AU2009276343A AU2009276343A AU2009276343A1 AU 2009276343 A1 AU2009276343 A1 AU 2009276343A1 AU 2009276343 A AU2009276343 A AU 2009276343A AU 2009276343 A AU2009276343 A AU 2009276343A AU 2009276343 A1 AU2009276343 A1 AU 2009276343A1
Authority
AU
Australia
Prior art keywords
alkyl
compound
optionally substituted
cycloalkyl
heterocycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009276343A
Other languages
English (en)
Inventor
Mansour Bassiri
Afsaneh Rahimi-Larijani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioxiness Pharmaceuticals Inc
Original Assignee
Bioxiness Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioxiness Pharmaceuticals Inc filed Critical Bioxiness Pharmaceuticals Inc
Publication of AU2009276343A1 publication Critical patent/AU2009276343A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/66—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2009276343A 2008-08-01 2009-07-31 Methionine analogs and methods of using same Abandoned AU2009276343A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8555608P 2008-08-01 2008-08-01
US61/085,556 2008-08-01
PCT/US2009/052474 WO2010014943A2 (en) 2008-08-01 2009-07-31 Methionine analogs and methods of using same

Publications (1)

Publication Number Publication Date
AU2009276343A1 true AU2009276343A1 (en) 2010-02-04

Family

ID=41414372

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009276343A Abandoned AU2009276343A1 (en) 2008-08-01 2009-07-31 Methionine analogs and methods of using same

Country Status (8)

Country Link
US (5) US8580859B2 (enExample)
EP (1) EP2326619B1 (enExample)
JP (1) JP5650642B2 (enExample)
CN (1) CN102171185A (enExample)
AU (1) AU2009276343A1 (enExample)
CA (1) CA2733390A1 (enExample)
IL (1) IL210956A0 (enExample)
WO (1) WO2010014943A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580859B2 (en) 2008-08-01 2013-11-12 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
US9200251B1 (en) 2011-03-31 2015-12-01 David Gordon Bermudes Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith
WO2019169029A1 (en) 2018-02-28 2019-09-06 Bioxiness Pharmaceuticals, Inc. Target specific chemotherapeutic agents

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR961832A (enExample) * 1943-03-20 1950-05-23
CH254537A (de) 1947-12-18 1948-05-15 Ag Sandoz Verfahren zur Herstellung eines neuen kapillaraktiven Stoffes.
DE1020144B (de) * 1956-07-02 1957-11-28 Dehydag Gmbh Wasch- und Reinigungsmittel
FR1390191A (fr) 1963-07-19 1965-02-26 Dehydag Gmbh Procédé de préparation de sulfobétaïnes à bases hétérocycliques de type aromatique
US3519683A (en) * 1967-03-31 1970-07-07 Meiji Seika Co Process for preparing 5-amino-5-deoxy-d-glucose-1-sulfonic acid
GB1580899A (en) * 1976-07-27 1980-12-10 Fujisawa Pharmaceutical Co Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof
JPS5463024A (en) 1977-10-27 1979-05-21 Fujisawa Pharmaceut Co Ltd 3-(n-formyl-n-hydroxyamino)-2(r)-hydroxypropyl-phosphonic acid, its preparation, and its use
US4169950A (en) * 1977-12-08 1979-10-02 Research Organics Amino-hydroxy-alkyl sulfonic acid zwitterions
IL61985A0 (en) 1980-02-01 1981-02-27 Sparamedica Ag Phosphinic and phosphonic acid derivatives,their manufacture and pharmaceutical compositions containing them
DE3273586D1 (en) 1981-11-02 1986-11-06 Ici Plc Substituted propyl phosphonic acid derivatives, their use as herbicides, herbicidal compositions containing them, and methods of preparing them
DE3245887A1 (de) 1982-12-11 1984-06-14 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung substituierter phosphon und phosphinsaeuren
GB8308506D0 (en) 1983-03-28 1983-05-05 Ici Plc Heterocyclic compounds
GB8410989D0 (en) 1984-04-30 1984-06-06 Ici Plc Heterocyclic compounds
DE3435156A1 (de) 1984-09-25 1986-04-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung der stereoisomeren von 1-amino-alkylphosphonsaeuren oder 1-aminoalkylphosphinsaeuren
JPS62215597A (ja) 1986-03-14 1987-09-22 Mitsubishi Chem Ind Ltd β−メルカプト−α−アミノエチルホスホン酸誘導体
IT1211792B (it) * 1987-09-21 1989-11-03 Sigma Tau Ind Farmaceuti O-alcanoil derivati dell'acido 3ammino-2-idrossipropansolfonico adattivita'anticonvulsivante e loro composizioni farmaceutiche per il trattamento terapeutico dell'epilessia
GB8727792D0 (en) 1987-11-27 1987-12-31 Merck Sharp & Dohme Therapeutic agents
SE8801729D0 (sv) * 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
JP2733511B2 (ja) 1988-10-22 1998-03-30 日本臓器製薬株式会社 新規アミノアルカン誘導体
JP3174566B2 (ja) 1990-04-20 2001-06-11 日本臓器製薬株式会社 アミノアルカン誘導体
EP0467856B1 (en) * 1990-07-19 1997-03-19 Nippon Zoki Pharmaceutical Co. Ltd. Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases
JP2724906B2 (ja) 1990-07-19 1998-03-09 日本臓器製薬株式会社 新規フェニルアラニルアミノアルカン誘導体
DE4124004C2 (de) 1991-07-19 1995-01-26 Hell Ag Linotype Vorrichtung zum Auf- und Abspannen von Filmmaterial und Betriebsweise der Vorrichtung
GB9122859D0 (en) * 1991-10-28 1991-12-11 Smithkline Beecham Plc Novel compounds
JPH07116382B2 (ja) 1992-01-28 1995-12-13 株式会社同仁化学研究所 水溶性メチレンビスジアルキルアニリン誘導体及びその塩類並びにそれらを用いた過酸化物質定量用組成物
GB9202779D0 (en) 1992-02-10 1992-03-25 Ici Plc Novel compounds
US5760021A (en) * 1992-05-29 1998-06-02 The Procter & Gamble Company Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
WO1994020508A1 (en) * 1993-03-08 1994-09-15 Eisai Co., Ltd. Phosphonic acid derivatives
CA2118985A1 (en) 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
EP0708079B1 (en) * 1993-07-09 1999-04-14 Kao Corporation 2-hydroxypropanediamine derivative and detergent composition containing the same
US5658749A (en) * 1994-04-05 1997-08-19 Corning Clinical Laboratories, Inc. Method for processing mycobacteria
JPH09316474A (ja) 1996-05-24 1997-12-09 Hitachi Maxell Ltd 潤滑性物質およびこの潤滑性物質を用いた磁気記録媒体
WO1998015525A1 (en) * 1996-10-07 1998-04-16 Sumitomo Pharmaceuticals Co., Ltd. Hydroxamic acids
CZ141399A3 (cs) 1996-10-24 1999-07-14 Novartis Ag Substituované aminoalkanfosfonové kyseliny, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
US6172057B1 (en) * 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
CN1265647A (zh) 1997-07-31 2000-09-06 普罗克特和甘保尔公司 无环金属蛋白酶抑制剂
US6403632B1 (en) * 2000-03-01 2002-06-11 Bristol Myers Squibb Pharma Co Lactam metalloprotease inhibitors
ZA988967B (en) 1997-10-03 2000-04-03 Du Pont Pharm Co Lactam metalloprotease inhibitors.
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
FR2780402B1 (fr) * 1998-06-30 2001-04-27 Adir Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1330661A (zh) 1998-12-10 2002-01-09 霍夫曼-拉罗奇有限公司 原胶原c端蛋白酶抑制剂
FR2788526B1 (fr) * 1999-01-20 2002-07-05 Inst Nat Sante Rech Med Composes tripeptidiques utiles a titre d'hinhibiteurs selectifs de l'aminopeptidase a et compositions pharmaceutiques correspondantes
EP1165500A1 (en) * 1999-04-02 2002-01-02 Du Pont Pharmaceuticals Company Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
FR2791982B1 (fr) * 1999-04-06 2002-12-27 Inst Nat Sante Rech Med Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques.
AU4249700A (en) * 1999-04-19 2000-11-02 Sumitomo Pharmaceuticals Company, Limited Hydroxamic acid derivative
HK1051137A1 (zh) * 1999-07-09 2003-07-25 Isis Innovation Limited 抑制疾病的化合物和製備移植用的細胞
JP4153647B2 (ja) 2000-04-05 2008-09-24 三菱重工業株式会社 フェントン反応抑制剤および一重項酸素産生抑制剤
AU2001279649A1 (en) 2000-06-08 2001-12-17 Jomaa Pharmaka Gmbh Use of organophosphorous hydroxamic acid derivatives for producing medicaments
WO2002018395A1 (en) * 2000-08-31 2002-03-07 Merck & Co., Inc. Phosphate derivatives as immunoregulatory agents
WO2002028829A2 (en) * 2000-09-25 2002-04-11 Questcor Pharmaceuticals, Inc. Peptide deformylase inhibitors
EP1361872A4 (en) 2000-10-03 2004-05-19 Univ Virginia NEW LYSOPHOSPHIC ACID RECEPTOR AGONISTS AND ANTAGONISTS
FR2816837A1 (fr) 2000-11-17 2002-05-24 Oreal Utilisation d'au moins un derive amino sulfonique dans une composition destinee a favoriser la desquamation de la peau
FR2821621B1 (fr) * 2001-03-05 2004-11-05 Oreal Polyurethannes anioniques a caractere elastique et leur utilisation dans des compositions cosmetiques
EP1469863A2 (en) * 2002-01-18 2004-10-27 Merck & Co., Inc. Selective s1p1/edg1 receptor agonists
ES2387803T3 (es) 2003-01-08 2012-10-02 Novartis Vaccines And Diagnostics, Inc. Agentes antibacterianos
DK1602660T3 (da) 2003-02-18 2011-05-23 Kyorin Seiyaku Kk Aminophosphonsyrederivater, additionssalte deraf og S1P-receptormodulatorer
AU2004249529A1 (en) 2003-06-23 2004-12-29 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
FR2858617A1 (fr) * 2003-08-06 2005-02-11 Inst Nat Sante Rech Med Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant
US7662856B2 (en) * 2003-08-29 2010-02-16 The University Of Houston System Compositions having antimycrobial activity including a hydroxamate or a hydroxamate and a hydroxlyamine
US20050107447A1 (en) * 2003-11-03 2005-05-19 Lynch Kevin R. Novel lysophosphatidic acid receptor agonists and antagonists
JP4182910B2 (ja) 2004-03-30 2008-11-19 ダイソー株式会社 スフィンゴミエリン類縁体とその製造法
AU2005310986A1 (en) * 2004-11-12 2006-06-08 Bellus Health (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
EP1836161B1 (en) * 2004-12-22 2016-07-20 BHI Limited Partnership Methods and compositions for treating amyloid-related diseases
KR20070121644A (ko) * 2005-01-14 2007-12-27 유리젠, 인코포레이티드 하부 요로 치료용 키트 및 개선된 조성물
JP2006257069A (ja) 2005-02-17 2006-09-28 Kemikurea:Kk 蛍光標識化スフィンゴシン１−リン酸メチレン置換体およびリン酸アルケニル置換体
JP2009520695A (ja) * 2005-12-15 2009-05-28 ヴィキュロン ファーマシューティカルズ インコーポレイテッド 抗菌活性を有するｎ−ヒドロキシアミド誘導体
EP2240019A4 (en) 2007-12-03 2011-11-16 Signum Biosciences Inc MIMETIC ACID COMPOUNDS FOR INHIBITING ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE
US8580859B2 (en) 2008-08-01 2013-11-12 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same

Also Published As

Publication number Publication date
US20110196014A1 (en) 2011-08-11
IL210956A0 (en) 2011-04-28
CN102171185A (zh) 2011-08-31
US8580859B2 (en) 2013-11-12
JP2011529921A (ja) 2011-12-15
EP2326619B1 (en) 2019-02-27
CA2733390A1 (en) 2010-02-04
WO2010014943A3 (en) 2011-01-13
US20140142189A1 (en) 2014-05-22
US20150329481A1 (en) 2015-11-19
JP5650642B2 (ja) 2015-01-07
US9695119B2 (en) 2017-07-04
US20170029369A1 (en) 2017-02-02
WO2010014943A2 (en) 2010-02-04
US20170267632A1 (en) 2017-09-21
EP2326619A2 (en) 2011-06-01

Similar Documents

Publication Publication Date Title
KR100418808B1 (ko) 금속단백질분해효소억제제
JP5564264B2 (ja) Ｎ−ハロゲン化アミノ化合物および誘導体
JP7221021B2 (ja) 毒性アルデヒド関連疾患および処置
US8324264B1 (en) Inhibitors of bacterial biofilms and related methods
JPH10504821A (ja) 金属タンパク質分解酵素阻害剤
US20090149509A1 (en) Novel pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
KR20010040621A (ko) 항균제
CN1902158A (zh) N,n－二卤代氨基酸及其衍生物
JP2005509594A (ja) Ｎａｄシンテターゼ阻害剤およびその使用
KR20010034861A (ko) 항박테리아제로서의 히드록삼산 유도체
US20170267632A1 (en) Methionine analogs and methods of using same
JP4109123B2 (ja) ペプチドデホルミラーゼ活性化プロドラッグ
AU2004226815B2 (en) Crystalline N-formyl hydroxylamine compounds
KR20050018809A (ko) 펩티드 디포르밀라아제 활성화 프로드러그
CZ20002889A3 (cs) Sloučeniny s antibakteriálními účinky

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted